Applied Nutrition Plc
APN · Main Market · Food, Beverage and Tobacco · mcap £684m · 281.5p
| Date | Type | Announcement | Day |
|---|---|---|---|
| 13 Oct 26 | Holding | Holding(s) in Company | |
| 12 Oct 26 | Holding | Holding(s) in Company | |
| 12 Oct 26 | Routine | Notice of Results & Presentations | |
| 09 Oct 26 | Holding | Holding(s) in Company | |
| 08 Oct 26 | Holding | Holding(s) in Company | |
| 07 Oct 26 | Holding | Holding(s) in Company | |
| 05 Oct 26 | Holding | Holding(s) in Company | |
| 05 Oct 26 | Holding | Holding(s) in Company | |
| 14 Sep 26 | Holding | Holding(s) in Company | |
| 14 Sep 26 | Holding | Holding(s) in Company | |
| 14 Sep 26 | Holding | Holding(s) in Company | |
| 11 Sep 26 | Director dealing | Director/PDMR Shareholding | |
| 11 Sep 26 | Fundraise | Result of Secondary Placing in Applied Nutrition
Founders sell 7m shares at 275p per share, representing 2.80% of issued capital. |
−1.9% |
| 10 Sep 26 | Fundraise | Proposed Secondary Placing in Applied Nutrition
CEO and COO propose to sell approximately 6m shares, representing 2.40% of issued capital. |
−1.5% |
| 26 Aug 26 | Trading update | FY26 Trading Update
FY26 adjusted EBITDA £43.3m and revenue £160m ahead of expectations; FY27 guidance £49m EBITDA and £205m revenue |
−1.6% |
| 30 Jun 26 | Director Declaration
In accordance with UK Listing Rule 6.4.9(2), Applied Nutrition plc (the "Company"), a leading sports nutrition, health and wellness brand, announces that Marnie Millard, a Non-Executive Director of the Company, has been |
−0.3% | |
| 04 Jun 26 | Director dealing | Director/PDMR Shareholding | |
| 01 Jun 26 | Trading update | Trading Update, Acquisition and Collaboration
Acquired US manufacturing facility from Nutrablend Group for $16m and signed collaboration with Mondelēz on SOUR PATCH KIDS branded products. |
+11.7% |
| 21 Apr 26 | Holding | Holding(s) in Company | |
| 21 Apr 26 | Holding | Holding(s) in Company | |
| 20 Apr 26 | Holding | Holding(s) in Company | |
| 16 Apr 26 | Results | Results of Secondary Placing in Applied Nutrition
JD Sports sells 22.75m Applied Nutrition shares, 9.1% stake, at £2.15 per share for £49m proceeds. |
−4.9% |
| 15 Apr 26 | Fundraise | Proposed Secondary Placing in Applied Nutrition
JD Sports selling approximately 11 million Applied Nutrition shares via placing. |
−3.6% |
| 13 Apr 26 | Director dealing | Director/PDMR Shareholding | |
| 23 Mar 26 | Results | Half-year Results
H1 FY26 revenue up 57% to £74.5m with adjusted EBITDA up 56% to £21.5m, ahead of expectations. |
−7.2% |
| 13 Mar 26 | Holding | Holding(s) in Company | |
| 17 Feb 26 | Trading update | H1 FY26 Trading Update
H1 FY26 revenue £74.5m, up 57%, ahead of expectations; FY26 guidance raised to £140m. |
+6.2% |
| 12 Jan 26 | Appointment of Joint Broker
Applied Nutrition (LSE: APN), a leading sports nutrition, health and wellness brand, is pleased to announce the appointment of Panmure Liberum Limited ("Panmure Liberum") as joint corporate broker, to work alongside Deut |
−2.3% | |
| 08 Jan 26 | Routine | Result of AGM | |
| 19 Dec 25 | Holding | Holding(s) in Company | |
| 19 Dec 25 | Holding | Holding(s) in Company | |
| 19 Dec 25 | Licensing agreement with Morrisons for food range
Applied Nutrition signs exclusive three-year licensing deal with Morrisons to launch 53 branded food products across 400 UK stores from January 2026. |
+2.4% | |
| 16 Dec 25 | Holding | Holding(s) in Company | |
| 16 Dec 25 | Holding | Holding(s) in Company | |
| 15 Dec 25 | Holding | Holding(s) in Company | |
| 09 Dec 25 | Holding | Holding(s) in Company | |
| 09 Dec 25 | Trading update | Trading Update
FY26 results expected to exceed market consensus by approximately 10%. |
+10.1% |
| 08 Dec 25 | Holding | Holding(s) in Company | |
| 04 Dec 25 | Holding | Holding(s) in Company | |
| 03 Dec 25 | Holding | Holding(s) in Company | |
| 01 Dec 25 | Holding | Holding(s) in Company | |
| 27 Nov 25 | Results | Annual Report and Accounts and Notice of AGM
Annual Report and Accounts and Notice of AGM |
+0.9% |
| 27 Nov 25 | Holding | Holding(s) in Company | |
| 18 Nov 25 | Holding | Holding(s) in Company | |
| 14 Nov 25 | Holding | Holding(s) in Company | |
| 10 Nov 25 | Holding | Holding(s) in Company | |
| 10 Nov 25 | Results | Final Results
FY25 revenue up 24.2% to £107.1m and adjusted EBITDA up 18.8% to £30.9m, ahead of IPO guidance. |
−2.7% |
| 06 Nov 25 | Holding | Holding(s) in Company | |
| 05 Nov 25 | Holding | Holding(s) in Company | |
| 03 Nov 25 | Holding | Holding(s) in Company | |
| 03 Nov 25 | Holding | Holding(s) in Company | |
| 31 Oct 25 | Holding | Holding(s) in Company | |
| 27 Oct 25 | Holding | Holding(s) in Company | |
| 24 Oct 25 | Holding | Holding(s) in Company | |
| 17 Oct 25 | Holding | Holding(s) in Company | |
| 17 Oct 25 | Holding | Holding(s) in Company | |
| 16 Oct 25 | Holding | Holding(s) in Company | |
| 15 Oct 25 | Holding | Holding(s) in Company | |
| 14 Oct 25 | Holding | Holding(s) in Company | |
| 10 Oct 25 | Holding | Holding(s) in Company | |
| 09 Oct 25 | Holding | Holding(s) in Company | |
| 08 Oct 25 | Holding | Holding(s) in Company | |
| 08 Oct 25 | Routine | Notice of Results and Presentations | |
| 06 Oct 25 | Holding | Holding(s) in Company |
Company filings. Not investment advice.